Profil bibliographique

Sasirekha Sivakumar

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

33Publications signalées

331Citations signalées

2Affiliations récentes

Les institutions déclarées

University of Massachusetts Chan Medical School Cancer Research Foundation

Les domaines associés

Click Chemistry and ApplicationsEstrogen and related hormone effectsCancer therapeutics and mechanismsCancer-related Molecular PathwaysDNA Repair Mechanisms

Les publications récentes

Accès ouvert 2025 article OpenAlex

2701P Estrogen receptor and AKT pathways as potential novel targets for MDM2-amplified well-differentiated and dedifferentiated liposarcoma (WD/DD LPS)

T.W-W. Chen, Srinivasan Rengarajan, Dexter X. Jin, Sasirekha Sivakumar

tw, us (code pays fourni par la source)

0 citations Annals of Oncology

Accès ouvert 2025 article OpenAlex

A Tetracycline-Inducible Promoter Replacement System for Schizosaccharomyces pombe

Samirul Bashir, Sasirekha Sivakumar, Nick Rhind

us (code pays fourni par la source)

0 citations PubMed

2023 conference-abstract OpenAlex

Abstract B172: Potent anti-tumor activity of a selective and orally bioavailable reversible covalent CDK12 inhibitor

Leena Khare, Ramulu Poddutoori, Subhendu Mukherjee, Samiulla DS et autres

in (code pays fourni par la source)

0 citations Molecular Cancer Therapeutics

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Methods from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Zhenhua J. Wu et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figures S20-S23 from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Zhenhua J. Wu et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figures S7-S10 from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Zhenhua J. Wu et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figures S1-S6 from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Zhenhua J. Wu et autres

0 citations

Accès ouvert 2023 other OpenAlex

Tables S1-S2 from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Zhenhua J. Wu et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figures S13-S19 from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Zhenhua J. Wu et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figures S11-S12 from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Zhenhua J. Wu et autres

0 citations

Accès ouvert 2023 other OpenAlex

Tables S3-S4 from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Zhenhua J. Wu et autres

0 citations

Accès ouvert 2023 other OpenAlex

Figures S13-S19 from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Zhenhua J. Wu et autres

0 citations

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.